Eli Lilly ’ s Humalog Junior KwikPen diabetes drug-device combo launches in U.S.

Eli Lilly‘s (NYSE:LLY) Humalog Junior KwikPen insulin lispro injection is available in the U.S. by prescription for people with diabetes, the company said today.
The drug-device combination product is designed as a pre-filled, disposable half-unit insulin pen.
Get the full story at our sister site, Drug Delivery Business News.
The post Eli Lilly’s Humalog Junior KwikPen diabetes drug-device combo launches in U.S. appeared first on MassDevice.

Source: Mass Device - October 4, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat Eli Lilly & Co. Source Type: news